Buy-Side Due Diligence Support for Life Sciences Investment Fund Manager
Buy-Side Due Diligence Support for Life Sciences Investment Fund Manager
An early-stage life sciences investment fund manager needed due diligence support on multiple potential biotechnology and medical device company investments.
The fund manager sought an independent perspective on key topics relevant to each target company, as well as valuation, transaction and strategic support throughout the investment process.
Reviewed each target company’s data room.
Spoke with each target company management, board members and advisors.
Performed primary and secondary market research pertinent to each target company, with an emphasis on interviews and comparable company/asset research.
Developed forecast and valuation models, as well as pro forma capitalization tables and associated sensitivity analyses.
RNA provided our financial models, summary charts, presentation materials and other written correspondence to the investment fund manager to facilitate investment committee meetings.
The investment fund made several investments in the target companies based on our findings, while rejecting investment opportunities in others based on our findings.
Enter your email address below to receive updates from RNA Advisors.